U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

In what could be a revolutionary stride in cancer care, scientists are exploring metabolism-targeting injections as a ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...

The World Health Organization will convene a meeting of its Emergency Committee next week to determine whether mpox remains a ...

FAT jabs such as Ozempic and Wegovy could be “game changers” in tackling bowel cancer within five years, researchers have claimed Evidence has already shown that injections of the weight-loss drugs ...

Metabolism-targeting injections could pave the way for a new treatments, detection and prevention of bowel cancer ...

Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...

Investing.com -- Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its development pipeline.

THE majority of strokes could be prevented, according to new guidelines aimed at helping people and their doctors do just ...

In a culture where the hush-hush overconsumption of drugs like Ozempic and Wegovy is quietly accepted, those who champion natural ageing and authentic beauty seem to be fighting a losing battle. This ...